Overexpression of the chromatin remodeler death-domain–associated protein in prostate cancer is an independent predictor of early prostate-specific antigen recurrence
Authors:
- Michael SchoopMSMichael Schoop
- Christoph PlassCPChristoph Plass
- Hartwig HulandHHHartwig Huland
- Markus GraefenMGMarkus Graefen
- Thomas SteuberTSThomas Steuber
- Thorsten SchlommTSThorsten Schlomm
- Ronald SimonRSRonald Simon
- Guido SauterGSGuido Sauter
- Hüseyin SirmaHSHüseyin Sirma
- Sarah MinnerSMSarah Minner
- 1 September 2013
- journal article
- Published by Elsevier in Human Pathology
- Vol. 44 (9) , 1789-1796
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Mutations and epimutations in the origin of cancerExperimental Cell Research, 2012
- Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastomaNature, 2012
- Molecular classification of prostate cancer using curated expression signaturesProceedings of the National Academy of Sciences, 2011
- ERG Status Is Unrelated to PSA Recurrence in Radically Operated Prostate Cancer in the Absence of Antihormonal TherapyClinical Cancer Research, 2011
- Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladderNature Genetics, 2011
- Altered Telomeres in Tumors with ATRX and DAXX MutationsScience, 2011
- DAXX / ATRX , MEN1 , and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine TumorsScience, 2011
- The genomic complexity of primary human prostate cancerNature, 2011
- Aktive Überwachung des ProstatakarzinomsDer Urologe, 2008
- Negative Modulation of Androgen Receptor Transcriptional Activity by DaxxMolecular and Cellular Biology, 2004